Targeting Triple-Negative Breast Cancer with Momordicine-I for Therapeutic Gain in Preclinical Models
Kousik Kesh(Saint Louis University), Ratna B. Ray(Saint Louis University)
Cited by 1
Related Papers
Functions of autophagy in normal and diseased liver
|Autophagy|2013|438
Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3
|Oncotarget|2016|187
Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death
|Oncotarget|2017|137
miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression
|Cells|2019|123
Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
|Cell Communication and Signaling|2019|74